Abstract
We report on a 45-year-old female who developed eosinophilic fasciitis, characterized by scleroderma-like skin indurations, predominantly on the extremities and chest, with joint contractures and intermittent blood eosinophilia. Histologic examination revealed fibrosis of muscle fascia and eosinophilic infiltration. High-dose systemic corticosteroid therapy was ineffective, but cyclosporine treatment led to remission.
This is a preview of subscription content, log in via an institution to check access.
References
Shulman LE (1974) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 1 [Suppl]:46
Mosconi S, Streit M, Bronimann M, Braathen LR (2002) Eosinophilic fasciitis (Shulman syndrome). Dermatology 205:204–206
Pouplin S, Daragon A, Le Loet X (1998) Treatment of eosinophilic fasciitis with methotrexate. J Rheumatol 25:606–607
Dziadzio L, Kelly EA, Panzer SE, Jarjour N, Huttenlocher A (2003) Cytokine abnormalities in a patient with eosinophilic fasciitis. Ann Allergy Asthma Immunol 90:452–455
Uckun A, Sipahi T, Akgun D, Oksal A (2002) Eosinophilic fasciitis successfully treated with oral hydroxyzine: a new therapeutic use of an old drug? Eur J Pediatr 161:118–119
Naschitz JE, Yeshurun D, Rosner J, Abrahamson JE, Misselevitcg I, Boss JH (1990) Treatment with cimetidine of atypical fasciitis panniculitis syndrome. Ann Rheum Dis 49:788–792
Romano C, Rubegni P, Aloe G, Stanghellini E, Ascenzo GD, Andreassi L, Fimiani M (2003) Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. JEADV 17:10–13
Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA (2003) Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7:382–386
Plotz SG, Simon H, Darsow U, Simon D et al (2003) Use of anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349:2334–2339
Capella GL, Casa-Alberighi OD, Finzi AF (2001) Therapeutic concepts in clinical dermatology: cyclosporine A in immunomediated and other dermatoses. Int J Dermatol 40:551–559
Laneuville P (1992) Cyclosporin A induced remission of CD4+ T-CLL associated with eosinophilia and fasciitis. Br J Haematol 80:252–254
Fleming CJ, Clarke P, Kemmet D (1997) Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin. Br J Dermatol 136:297–299
Peter RU, Ruzicka T (1992) Cyclosporin A in the therapy of inflammatory dermatoses. Hautarzt 43:687–694
Gisslinger H, Burghuber OC, Stacher G, Schwarz W, Punzengruber C, Graninger W et al (1991) Efficacy of cyclosporin A in systemic sclerosis. Clin Exp Rheumatol 9:383–390
Worl B, Hein R, Krieg T, Meurer M (1990) Cyclosporine A in localized and systemic sleroderma—a clinical study. Dermatologica 181:215–220
Hayashi N, Igarashi A, Matsuyama T, Harada S (2000) Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin. Br J Dermatol 142:830–832
Lohi J, Kaharai VM, Keski-Oja J (1994) Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol 102:938–944
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bukiej, A., Dropiński, J., Dyduch, G. et al. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol 24, 634–636 (2005). https://doi.org/10.1007/s10067-005-1099-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1099-4